We have been awarded a grant from the Royal Society of Chemistry for a chemistry intern to spend 3 months… read more →
We are pleased that a paper by Salter et al., 2018 has been published in Xenobiotica. The paper, entitled Microbial… read more →
A 2018 Nature Reviews Drug Discovery paper by Bostrom et al on “Expanding the medicinal chemistry synthetic toolbox” features examples… read more →
Zhou et al. presented a poster at the 2018 ISSX Conference in Montreal on “Elimination of [14C]-LY3023414 by Aldehyde Oxidase… read more →
Hypha Discovery have issued a policy detailing our position on data protection in relation to the GDPR regulations that came… read more →
Biocatalytic optimisation of lead compounds by late stage functionalisation is becoming more widely applied within pharma companies to rapidly access… read more →
19th February 2018 We are pleased to announce that Hypha have moved from Uxbridge to larger facilities in Slough. The… read more →
Liam is attending the Drug Discovery Chemistry Lead Optimization for Drug Metabolism and Safety meeting on April 6th 2018 in… read more →
Single-step microbial production of sequential hydroxylated glucuronidated metabolites is the topic of our first scientific newsletter for 2018. Many… read more →
Hypha’s newsletter for Q4 2017 focusses on the selective production of N-oxide metabolites, especially relevant where there is potential for… read more →